Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kymera Therapeutics, Inc. | 18,986 | reported | 02 Mar 2023 | tx 7+221,895−714 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2023 | SALE | Kymera Therapeutics, Inc. | 164 | 31.40 USD | |
| 01 Mar 2023 | GRANT_AWARD | Kymera Therapeutics, Inc. | 10,557 | 0.00 USD | |
| 02 Mar 2023 | SALE | Kymera Therapeutics, Inc. | 550 | 30.88 USD | |
| 01 Mar 2023 | GRANT_AWARD | Kymera Therapeutics, Inc. | 63,338 | 0.00 USD | deriv |
| 01 Mar 2022 | GRANT_AWARD | Kymera Therapeutics, Inc. | 7,000 | 0.00 USD | |
| 01 Mar 2022 | GRANT_AWARD | Kymera Therapeutics, Inc. | 41,000 | 0.00 USD | deriv |
| 21 Jun 2021 | GRANT_AWARD | Kymera Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |